CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Tilray, Inc. - TLRY CFD

2.56
1.54%
0.09
Low: 2.53
High: 2.6
Market Trading Hours* (UTC) Opens on Monday at 08:10

Mon - Thu: 08:10 - 00:00

Fri: 08:10 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.09
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Tilray Brands Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.6
Open* 2.56
1-Year Change* -54.85%
Day's Range* 2.53 - 2.6
52 wk Range 2.28-9.08
Average Volume (10 days) 14.58M
Average Volume (3 months) 310.92M
Market Cap 1.59B
P/E Ratio -100.00K
Shares Outstanding 613.18M
Revenue 602.54M
EPS -1.08
Dividend (Yield %) N/A
Beta 2.70
Next Earnings Date Apr 4, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 23, 2023 2.56 0.00 0.00% 2.56 2.68 2.54
Mar 22, 2023 2.58 -0.10 -3.73% 2.68 2.70 2.54
Mar 21, 2023 2.63 0.16 6.48% 2.47 2.70 2.44
Mar 20, 2023 2.45 -0.06 -2.39% 2.51 2.61 2.43
Mar 17, 2023 2.60 0.07 2.77% 2.53 2.63 2.48
Mar 16, 2023 2.51 0.18 7.73% 2.33 2.65 2.30
Mar 15, 2023 2.36 0.00 0.00% 2.36 2.38 2.26
Mar 14, 2023 2.37 -0.07 -2.87% 2.44 2.55 2.36
Mar 13, 2023 2.40 -0.02 -0.83% 2.42 2.50 2.32
Mar 10, 2023 2.40 -0.09 -3.61% 2.49 2.52 2.38
Mar 9, 2023 2.51 -0.06 -2.33% 2.57 2.63 2.49
Mar 8, 2023 2.57 -0.04 -1.53% 2.61 2.62 2.55
Mar 7, 2023 2.61 -0.06 -2.25% 2.67 2.70 2.59
Mar 6, 2023 2.67 -0.07 -2.55% 2.74 2.78 2.65
Mar 3, 2023 2.73 0.05 1.87% 2.68 2.77 2.68
Mar 2, 2023 2.68 -0.04 -1.47% 2.72 2.74 2.68
Mar 1, 2023 2.72 -0.06 -2.16% 2.78 2.81 2.72
Feb 28, 2023 2.76 0.03 1.10% 2.73 2.79 2.72
Feb 27, 2023 2.73 -0.02 -0.73% 2.75 2.83 2.72
Feb 24, 2023 2.77 -0.04 -1.42% 2.81 2.81 2.75

Tilray, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 513.085 210.482 166.979 43.13 20.538
Revenue 513.085 210.482 166.979 43.13 20.538
Cost of Revenue, Total 389.903 185.827 190.475 28.855 9.161
Gross Profit 123.182 24.655 -23.496 14.275 11.377
Total Operating Expense 645.256 350.488 468.681 100.78 28.036
Selling/General/Admin. Expenses, Total 155.69 135.569 173.111 66.063 15.609
Research & Development 0.83 4.411 6.558 4.264 3.171
Depreciation / Amortization 35.221 16.442 13.39 1.598 0.095
Operating Income -132.171 -140.006 -301.702 -57.65 -7.498
Interest Income (Expense), Net Non-Operating -223.587 -26.05 -27.982 -16.344 -0.323
Other, Net 9.249 -110.619 2.501 1.82 0.012
Net Income Before Taxes -344.986 -276.675 -329.619 -72.174 -7.809
Net Income After Taxes -336.014 -271.073 -321.169 -67.723 -7.809
Net Income Before Extra. Items -367.421 -271.073 -321.169 -67.723 -7.809
Net Income -367.421 -271.073 -321.169 -67.723 -7.809
Income Available to Common Excl. Extra. Items -367.421 -271.073 -321.169 -67.723 -7.809
Income Available to Common Incl. Extra. Items -367.421 -271.073 -321.169 -67.723 -7.809
Diluted Net Income -367.421 -271.073 -321.169 -67.723 -7.809
Diluted Weighted Average Shares 269.55 126.042 100.456 83.0097 91.794
Diluted EPS Excluding Extraordinary Items -1.36309 -2.15066 -3.19712 -0.81584 -0.08507
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.36676 -2.13903 -2.65956 -0.81584 -0.08507
Interest Expense (Income) - Net Operating 5.983 4.504
Unusual Expense (Income) 0 2.256 80.643
Gain (Loss) on Sale of Assets 1.523 -2.436
Other Operating Expenses, Total 63.612
Minority Interest -31.407
Feb 2022 Nov 2021 Aug 2021 May 2021 Mar 2021
Total revenue 151.871 155.153 168.023 513.085 48.021
Revenue 151.871 155.153 168.023 513.085 48.021
Cost of Revenue, Total 112.042 122.387 117.068 389.903 34.518
Gross Profit 39.829 32.766 50.955 123.182 13.503
Total Operating Expense 171.633 209.837 236.555 645.256 121.331
Selling/General/Admin. Expenses, Total 54.664 49.799 62.384 155.69 34.501
Research & Development 0.164 0.515 0.785 0.83 1.202
Depreciation / Amortization 24.59 29.016 30.739 35.221 3.498
Interest Expense (Income) - Net Operating 1.787
Unusual Expense (Income) 0 45.825
Operating Income -19.762 -54.684 -68.532 -132.171 -73.31
Interest Income (Expense), Net Non-Operating 47.942 34.4 23.157 -223.587 -6.217
Other, Net 22.465 20.41 15.533 9.249 -261.685
Net Income Before Taxes 50.645 0.126 -29.842 -344.986 -341.212
Net Income After Taxes 52.475 5.797 -34.604 -336.014 -340.955
Net Income Before Extra. Items 43.19 -0.201 -41.649 -367.421 -340.955
Net Income 43.19 -0.201 -41.649 -367.421 -340.955
Income Available to Common Excl. Extra. Items 43.19 -0.201 -41.649 -367.421 -340.955
Income Available to Common Incl. Extra. Items 43.19 -0.201 -41.649 -367.421 -340.955
Diluted Net Income 43.19 -0.201 -41.649 -367.421 -340.955
Diluted Weighted Average Shares 488.547 460.254 449.398 269.55 169.489
Diluted EPS Excluding Extraordinary Items 0.08841 -0.00044 -0.09268 -1.36309 -2.01166
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.08841 -0.00044 -0.09268 -1.36676 -1.83592
Other Operating Expenses, Total -19.827 8.12 25.579 63.612
Gain (Loss) on Sale of Assets 1.523
Minority Interest -9.285 -5.998 -7.045 -31.407
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 883.609 347.02 259.027 554.302 12.403
Cash and Short Term Investments 488.466 189.702 96.791 517.59 2.323
Cash 2.323
Total Receivables, Net 99.125 41.155 43.038 17.494 2.114
Accounts Receivable - Trade, Net 87.309 29.033 36.873 16.525 0.983
Total Inventory 256.429 93.645 87.861 16.211 7.421
Prepaid Expenses 31.012 6.542 5.847 3.007 0.545
Total Assets 6025.36 945.949 896.33 656.667 53.948
Property/Plant/Equipment, Total - Net 668.965 217.544 201.731 80.214 39.985
Property/Plant/Equipment, Total - Gross 745.841 245.419 218.848 87.714 44.565
Accumulated Depreciation, Total -76.876 -27.875 -17.117 -7.5 -4.58
Intangibles, Net 1605.92 186.445 228.828 4.486 0.934
Other Long Term Assets, Total 8.285 4.356 7.861 0.754 0.626
Total Current Liabilities 401.241 181.282 92.427 25.937 50.221
Accounts Payable 57.706 17.776 39.125 10.649 5.563
Accrued Expenses 143.956 41.359 51.382 14.818 2.021
Notes Payable/Short Term Debt 8.717 0 0 0 32.826
Current Port. of LT Debt/Capital Leases 37.273 1.5 0.47 9.811
Total Liabilities 1566.29 572.05 611.059 459.014 58.8
Total Long Term Debt 870.591 306.259 444.362 428.653 8.579
Long Term Debt 835.11 306.259 430.21 420.367 0
Capital Lease Obligations 35.481 14.152 8.286 8.579
Total Equity 4459.07 373.899 285.271 197.653 -4.852
Common Stock 0.046 0.016 0.011 0.01 0
Additional Paid-In Capital 4792.41 1095.78 705.671 302.057 31.736
Retained Earnings (Accumulated Deficit) -486.05 -730.103 -430.13 -108.177 -40.454
Other Equity, Total 152.668 8.205 9.719 3.763 3.866
Total Liabilities & Shareholders’ Equity 6025.36 945.949 896.33 656.667 53.948
Total Common Shares Outstanding 446.441 158.456 102.781 93.1709 91.794
Cash & Equivalents 488.466 189.702 96.791 487.255
Short Term Investments 0 30.335
Long Term Investments 25.791 23.669 35.632 16.911
Deferred Income Tax 265.845 49.274 53.363 4.424
Other Current Assets, Total 8.577 15.976 25.49
Goodwill, Net 2832.79 166.915 163.251
Other Current Liabilities, Total 153.589 120.647 1.92
Other Liabilities, Total 22.372 35.235 20.907
Minority Interest 6.243
Feb 2022 Nov 2021 Aug 2021 May 2021 Mar 2021
Total Current Assets 695.785 708.278 844.618 883.609 571.969
Cash and Short Term Investments 279.214 331.783 376.297 488.466 416.37
Cash & Equivalents 279.214 331.783 376.297 488.466 416.37
Total Receivables, Net 91.068 86.135 99.547 99.125 44.653
Accounts Receivable - Trade, Net 89.895 84.575 97.177 87.309 28.304
Total Inventory 273.292 233.02 251.507 256.429 96.544
Prepaid Expenses 52.211 57.34 117.267 31.012 5.117
Other Current Assets, Total 8.577 9.285
Total Assets 5819.44 5763.49 5986.35 6025.36 1168.24
Property/Plant/Equipment, Total - Net 621.323 618.182 639.122 668.965 215.249
Property/Plant/Equipment, Total - Gross 768.401 745.753 756.191 745.841 245.836
Accumulated Depreciation, Total -147.078 -127.571 -117.07 -76.876 -30.587
Goodwill, Net 2835.1 2814.16 2809.13 2832.79 169.079
Intangibles, Net 1528.96 1450.02 1502.81 1605.92 186.222
Long Term Investments 137.952 172.684 190.469 25.791 20.183
Other Long Term Assets, Total 0.314 0.164 0.198 8.285 5.542
Total Current Liabilities 282.427 314.928 526.83 401.241 283.989
Accounts Payable 70.249 64.98 61.99 57.706 48.289
Accrued Expenses 68.018 91.951 118.008 143.956 61.849
Notes Payable/Short Term Debt 17.496 8.736 9.203 8.717 0
Current Port. of LT Debt/Capital Leases 70.176 31.51 30.837 37.273 49.547
Other Current Liabilities, Total 56.488 117.751 306.792 153.589 124.304
Total Liabilities 1192.2 1327.2 1666.88 1566.29 627.613
Total Long Term Debt 622.285 706.673 776.557 870.591 259.443
Long Term Debt 622.285 706.673 776.557 835.11 259.443
Deferred Income Tax 237.208 219.311 239.373 265.845 49.293
Other Liabilities, Total 16.503 49.585 57.836 22.372 34.888
Total Equity 4627.24 4436.29 4319.47 4459.07 540.631
Common Stock 0.048 0.046 0.046 0.046 0.018
Additional Paid-In Capital 5110.89 4954.55 4795.88 4792.41 1599.71
Retained Earnings (Accumulated Deficit) -484.71 -527.9 -527.699 -486.05 -1071.06
Other Equity, Total 1.01 9.595 51.247 152.668 11.958
Total Liabilities & Shareholders’ Equity 5819.44 5763.49 5986.35 6025.36 1168.24
Total Common Shares Outstanding 480.738 463.802 450.523 446.441 447.371
Capital Lease Obligations 35.481
Minority Interest 33.773 36.701 66.283 6.243
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -336.014 -271.073 -321.169 -67.723 -7.809
Cash From Operating Activities -44.717 -129.351 -258.065 -46.248 -6.4
Cash From Operating Activities 67.832 18.654 15.849 3.562 1.853
Non-Cash Items 299.273 188.379 176.669 35.987 -0.316
Cash Interest Paid 27.588 28.206 1.189 1.157
Changes in Working Capital -50.935 -59.935 -120.567 -13.589 -0.128
Cash From Investing Activities 46.105 -41.68 -253.181 -98.62 -11.418
Capital Expenditures -38.874 -44.644 -78.616 -54.457 -11.441
Other Investing Cash Flow Items, Total 84.979 2.964 -174.565 -44.163 0.023
Cash From Financing Activities 124.308 264.847 114.7 630.998 12.235
Issuance (Retirement) of Debt, Net 45.509 44.79 -0.504 417.646 12.235
Foreign Exchange Effects 2.124 -0.905 6.082 -1.198 0.375
Net Change in Cash 127.82 92.911 -390.464 484.932 -5.208
Deferred Taxes -24.873 -5.376 -8.847 -4.485
Financing Cash Flow Items -23.895 -0.147 3.687 -15.299
Issuance (Retirement) of Stock, Net 102.694 220.204 111.517 228.651
Cash Taxes Paid 5.623
Feb 2022 Nov 2021 Aug 2021 May 2021 Mar 2021
Net income/Starting Line 23.668 -28.807 -34.604 -336.014 -340.955
Cash From Operating Activities -156.738 -110.348 -93.227 -44.717 -13.008
Cash From Operating Activities 113.824 76.804 39.333 67.832 4.908
Deferred Taxes -17.296 -11.228 -24.873 -24.873 -0.635
Non-Cash Items -201.064 -102.448 -38.272 299.273 275.706
Cash Interest Paid 0 0 0 0.912
Changes in Working Capital -75.87 -44.669 -34.811 -50.935 47.968
Cash From Investing Activities -16.618 -15.592 -8.62 46.105 -0.069
Capital Expenditures -28.47 -23.856 -16.316 -38.874 -2.466
Other Investing Cash Flow Items, Total 11.852 8.264 7.696 84.979 2.397
Cash From Financing Activities -33.612 -28.047 -8.028 124.308 234.081
Financing Cash Flow Items -23.895 -0.375
Issuance (Retirement) of Stock, Net -3.149 -3.927 0 102.694 235.765
Issuance (Retirement) of Debt, Net -30.463 -24.12 -8.028 45.509 -1.309
Foreign Exchange Effects -2.284 -2.696 -2.294 2.124 5.664
Net Change in Cash -209.252 -156.683 -112.169 127.82 226.668
Cash Taxes Paid 0 0 5.623
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Kennedy (Brendan) Individual Investor 1.1021 6809136 -350000 2022-11-07 LOW
Susquehanna International Group, LLP Investment Advisor 0.6741 4164604 -4419952 2022-12-31 MED
Horizons ETFs Management (Canada) Inc. Investment Advisor/Hedge Fund 0.5312 3281756 -16378 2023-02-28 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 0.3963 2448494 2448494 2022-12-31 HIGH
Prentice Capital Management, L.P. Hedge Fund 0.3924 2424181 1366831 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.3908 2414786 202405 2022-12-31 LOW
Mirae Asset Global Investments (USA) LLC Investment Advisor 0.3854 2380893 1151898 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.3765 2326038 -374708 2022-12-31 HIGH
D. E. Shaw & Co., L.P. Hedge Fund 0.3683 2275455 -1124343 2022-12-31 MED
National Bank of Canada Bank and Trust 0.3565 2202338 2156658 2022-12-31 HIGH
Morgan Stanley & Co. LLC Research Firm 0.3171 1959138 -1316993 2022-12-31 MED
BMO Asset Management Inc. Investment Advisor 0.2411 1489340 15458 2022-12-31 LOW
Sculptor Capital Management, Inc Hedge Fund 0.2163 1336504 0 2022-12-31 MED
Schweizerische Nationalbank Bank and Trust 0.2096 1295138 114900 2022-12-31 LOW
Alyeska Investment Group, L.P. Hedge Fund 0.2027 1252060 -350000 2022-12-31 HIGH
PSP Investments Pension Fund 0.1919 1185766 -252800 2022-12-31 MED
AdvisorShares Investments, LLC Investment Advisor 0.1885 1164914 0 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1747 1079596 45093 2022-12-31 LOW
TD Asset Management Inc. Investment Advisor 0.1713 1058634 1000 2022-12-31 LOW
California Public Employees' Retirement System Pension Fund 0.1615 997617 -38538 2022-12-31 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Tilray Company profile

Join Capital.com and start following all the ups and down of the Tilray share price today

Tilray Inc. (TLRY) is a pharmaceutical company that is engaged in the research, cultivation, production and distribution of medical and recreational cannabis and cannabinoids. The firm operates through two key divisions – Cannabis and Hemp – and runs a diversified portfolio of brands, including Canaca, Dubon, Yukon Rove and Manitoba Harvest. Its products are available to hospitals, pharmacies, physicians and patients, as well as researchers.

Incorporated in the US and headquartered in Canada, Tilray has presence in a number of countries, including Argentina, Chile, Australia, New Zealand, Germany, Cyprus, Switzerland, UK, Ireland, Portugal and South Africa.

Tilray stock is listed on the Nasdaq Stock Market under the ticker symbol TLRY.

Watch the TLRY share price in real-time at Capital.com.

The company was founded in 2013 as a subsidiary of US-based Privateer Holdings, a private equity firm that invests exclusively in the cannabis industry. 

In 2018, Tilray partnered with Sandoz, a subsidiary of Novartis (NOVN), to co-brand and distribute Tilray's non-smokable medical cannabis products in legal markets globally. It also announced a $100m joint venture with AB InBev, the world's largest brewer. 

In 2019, it signed a $250m revenue-sharing deal with New York City-based Authentic Brands Group (ABG) to leverage its brand names to develop, market and distribute cannabis products. Also in 2019, Tilray acquired Smith & Sinclair, FOUR20, Natura Naturals Holdings and Manitoba Harvest. 

In December 2020, the company announced its plans to merge with Aphria to create the world’s largest cannabis company by revenue that would continue operating under Tilray's name and trade as TLRY. 

With Capital.com’s Tilray stock chart you can not only quickly view the current TLRY share price, but also trace the company’s share value in historic terms.

In July 2018, Tilray became the first pure-play cannabis company to go public on a major US stock exchange, floating its shares on the Nasdaq exchange at a price of $17 per share. In its first day of trading, the company's stock gained more than 30 per cent, closing at $22.39. But after experiencing a stellar rise to $300 per share by September 19, 2018, it entered a downtrend. With the exception of occasional upside fluctuations, the Tilray stock price was falling steadily, bottoming out at $2.43 in March 2020 in the market’s initial reaction to the Covid-19 pandemic. 

Throughout 2020, TLRY stock had mainly traded below the $10 per share level, closing the year at $9 per share. In January 2021, the share price doubled from $9 to $18, soaring to close at $63.91 per share on February 10. The rally was driven by the warming political landscape for cannabis producers, as well as Reddit-backed retail investors who, at that time, short-squeezed a number of stocks, including GameStop (GME) and AMC Entertainment (AMC). The momentum was short-lived and by February 12, 2021, TRLY shares closed the trading session at $29. 

You can go long or short on the company’s shares using Capital.com’s proprietary trading platform.

Industry: Pharmaceuticals (NEC)

655 Madison Avenue
19Th Floor
NEW YORK
NEW YORK 10065
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee -0.0025%
Overnight fee time 21:00 (UTC)
Spread 0.03

Gold

1,978.85 Price
-0.760% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0097%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

12,798.80 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0241%
Short position overnight fee 0.0018%
Overnight fee time 21:00 (UTC)
Spread 3.0

XRP/USD

0.43 Price
-4.170% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00336

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading